Loading clinical trials...
Loading clinical trials...
A Randomized Phase II/III Study Comparing Stereotactic Body Radiotherapy(SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients With Spinal Metastases
Conditions
Interventions
20 Gy in 5 fractions
Conventional SBRT: 24 Gy in 2 fractions
Locations
22
Australia
Auckland City Hospital
Grafton, Aucklund, Australia
Liverpool Cancer Therapy Centre, Liverpool Hospital
Liverpool, New South Wales, Australia
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Peter McCallum Cancer Institute
Melbourne, Victoria, Australia
Peter Mac - Sunshine Hospital
St Albans, Victoria, Australia
Start Date
January 4, 2016
Primary Completion Date
July 21, 2020
Completion Date
August 16, 2021
Last Updated
February 13, 2024
NCT05589701
NCT06548061
NCT06244264
NCT04863612
NCT04497051
NCT02987153
Lead Sponsor
Canadian Cancer Trials Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions